Vitamin d receptor deficiency and low vitamin d diet stimulate aortic calcification and osteogenic key factor expression in mice

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Schmidt, Nadine ^a   Brandsch, Corinna ^a   Kühne, Hagen ^a   Thiele, Alexandra ^a   Hirche, Frank ^a   Stangl, Gabriele I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIFEDIOL; CALCIUM; COLECALCIFEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHORUS; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; VITAMIN D RECEPTOR; BMP2 PROTEIN, MOUSE; CALCITRIOL RECEPTOR; HOMEODOMAIN PROTEIN; LIPID; RUNX2 PROTEIN, MOUSE; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; AORTA VALVE CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET THERAPY; FEMUR; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; 129 MOUSE; ANIMAL; AORTA; AORTA DISEASE; AORTA VALVE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD; C57BL MOUSE; CALCINOSIS; DIET; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; AORTA; AORTIC DISEASES; AORTIC VALVE; ATHEROSCLEROSIS; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; CALCIUM; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DIET; FEMUR; HOMEODOMAIN PROTEINS; LIPIDS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORUS; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CALCITRIOL; RECEPTORS, LDL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84859950099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035316     Document Type: Article

References (34)

1. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, et al. (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260: 245-254.
2. Viñas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, et al. (2011) Projected prevalence of inadequate nutrient intakes in Europe. Ann Nutr Metab 59: 84-95.
3. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr, et al. (1980) Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210: 203-205.
4. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349.
5. Giovannucci E, Liu Y, Hollis BW, Rimm EB, (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
6. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
7. Artaza JN, Mehrotra R, Norris KC, (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4: 1515-1522.
8. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, et al. (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170: 1032-1039.
9. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B, (2008) Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19: 1613-1619.
10. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19: 1379-1388.
11. Nagpal S, Na S, Rathnachalam R, (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687.
12. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU, (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103: 416-419.
13. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA, (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19: 1509-1519.
14. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, et al. (2010) Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30: 2495-2503.
15. Cannata-Andia JB, Rodrigues-Garcia M, Carrillo-Lopez N, Diaz-Naves, Diaz-Lopez B, (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17: S267-S273.
16. Kelly RP, Tunin R, Kass DA, (1992) Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res 71: 490-502.
17. Allison MA, Criqui MH, Wright CM, (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24: 331-336.
18. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760.
19. Fleet JC, Gliniak C, Zhang Z, Xue Y, Smith KB, et al. (2008) Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J Nutr 138: 1114-1120.
20. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832.
21. Breslow JL, (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3: 600-601.
22. Braunwald E, (1997) Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337: 1360-1369.
23. Ross R, Glomset JA, (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332-1339.
24. Abedin M, Tintut Y, Demer LL, (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161-1170.
25. Mizobuchi M, Towler D, Slatopolsky E, (2009) Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20: 1453-1464.
26. Zebboudi AF, Shin V, Bostrom K, (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90: 756-765.
27. Towler DA, Shao JS, Cheng SL, Pingsterhaus JM, Loewy AP, (2006) Osteogenic regulation of vascular calcification. Ann N Y Acad Sci 1068: 327-333.
28. Speer MY, Li X, Hiremath PG, Giacelli CM, (2010) Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem 110: 935-947.
29. Johnson RC, Leopold JA, Loscalzo J, (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059.
30. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H, (1999) Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2112-2118.
31. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, et al. (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147-1154.
32. National Research Council (NRC), Committee on Animal Nutrition (1995) Nutrient Requirements of Laboratory Animals Washington, D.C. National Academy Press pp. 80-102.
33. Higashi T, Shibayama Y, Fuji M, Shimada K, (2008) Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal Bioanal Chem 391: 229-238.
34. Bassler R, Buchholz H, (1993) Die chemische Untersuchung von Futtermitteln. Band II Darmstadt VDLUFA Verlag.